Australian consumer spending shifts toward weight-loss drugs and discount brands amid cost-of-living pressure

Corporate reporting data indicates a pivot in Australian consumer behavior, characterized by increased demand for GLP-1 weight-loss medications and lower-cost 'dupe' retail alternatives. This trend reflects a strategic response to persistent inflationary pressures and reduced discretionary spending on non-essential goods.